SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study
Abstract Background: Type 2 diabetes mellitus (T2DM) is a progressive chronic disease associated with severe microvascular and macrovascular complications. Our aim is to assess the real world effectiveness of SGT" inhibitors in achieving metabolic therapeutic goals. Methods: A retrospective, ob...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2017
|
| Online Access: | http://eprints.uanl.mx/17587/1/372.pdf |